Research & Development



  “這句話的意思好像是要封你為什麼來著?”   汲黯放聲笑道︰“他們本來就是常人,雖說這二人一勇猛一聰慧。青青草超碰免费视频av   桑弘羊微微一笑,用茶碗的蓋子輕輕刮一下茶水上的浮沫,喝了一口金黃的茶水,自言自語道︰“以前,是這些碩鼠在吸我大漢百姓的血,今日,終于輪到大漢百姓吸這些碩鼠的血了。”哥哥干   董仲舒大笑道︰“如此,便一言為定!”   外殼堅固與否,就在冠軍侯,永安侯身上,目前看,永安侯經營的河西四郡還算平安,所以,微臣以為沒有換將的必要。狠狠干   不過呢,這畢竟是一種表象,每當謝寧三兄弟開始吃飯的時候,他都能感受到那些匈奴人投注在他們身上的焦灼的目光。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo